// April 18, 2024
USP’s commitment to ESG considerations for a healthier, more sustainable world
At the U.S.
At the U.S.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event
With significant innovations in pharmaceuticals, including biologic drugs
The quality of medicine and how it’s delivered to patients is fundamental to treating illness and